104 related articles for article (PubMed ID: 23311366)
1. On optimal and suboptimal treatment strategies for a mathematical model of leukemia.
Fimmel E; Semenov YS; Bratus AS
Math Biosci Eng; 2013 Feb; 10(1):151-65. PubMed ID: 23311366
[TBL] [Abstract][Full Text] [Related]
2. On assessing quality of therapy in non-linear distributed mathematical models for brain tumor growth dynamics.
Bratus AS; Fimmel E; Kovalenko SY
Math Biosci; 2014 Feb; 248():88-96. PubMed ID: 24384228
[TBL] [Abstract][Full Text] [Related]
3. Mathematical analysis and simulations involving chemotherapy and surgery on large human tumours under a suitable cell-kill functional response.
Rodrigues DS; de Arruda Mancera PF
Math Biosci Eng; 2013 Feb; 10(1):221-34. PubMed ID: 23311370
[TBL] [Abstract][Full Text] [Related]
4. Determination of an optimal control strategy for drug administration in tumor treatment using multi-objective optimization differential evolution.
Lobato FS; Machado VS; Steffen V
Comput Methods Programs Biomed; 2016 Jul; 131():51-61. PubMed ID: 27265048
[TBL] [Abstract][Full Text] [Related]
5. Optimal strategy in chemotherapy for a Gompertzian model of cancer growth.
Maroński R
Acta Bioeng Biomech; 2008; 10(2):81-4. PubMed ID: 19032003
[TBL] [Abstract][Full Text] [Related]
6. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.
Ledzewicz U; Schättler H
Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967
[TBL] [Abstract][Full Text] [Related]
7. Optimal and suboptimal protocols for a mathematical model for tumor anti-angiogenesis in combination with chemotherapy.
Ledzewicz U; Maurer H; Schättler H
Math Biosci Eng; 2011 Apr; 8(2):307-23. PubMed ID: 21631132
[TBL] [Abstract][Full Text] [Related]
8. An optimal dynamic inversion-based neuro-adaptive approach for treatment of chronic myelogenous leukemia.
Padhi R; Kothari M
Comput Methods Programs Biomed; 2007 Sep; 87(3):208-24. PubMed ID: 17618012
[TBL] [Abstract][Full Text] [Related]
9. Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis.
Ledzewicz U; Schättler H
J Theor Biol; 2008 May; 252(2):295-312. PubMed ID: 18371982
[TBL] [Abstract][Full Text] [Related]
10. The stochastic blueness of leukemic stem cells in experimental antineoplastic therapy.
Janković GM; Colović MO; Petrović MO; Rolović ZN; Janosević S
Exp Hematol; 1993 Oct; 21(11):1399-400. PubMed ID: 8405217
[No Abstract] [Full Text] [Related]
11. Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment.
Ledzewicz U; Marriott J; Maurer H; Schättler H
Math Med Biol; 2010 Jun; 27(2):157-79. PubMed ID: 20513667
[TBL] [Abstract][Full Text] [Related]
12. Optimal control oriented to therapy for a free-boundary tumor growth model.
Calzada MC; Fernández-Cara E; Marín M
J Theor Biol; 2013 May; 325():1-11. PubMed ID: 23485361
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors: a new perspective for the treatment of leukemia.
Abujamra AL; Dos Santos MP; Roesler R; Schwartsmann G; Brunetto AL
Leuk Res; 2010 Jun; 34(6):687-95. PubMed ID: 19762081
[TBL] [Abstract][Full Text] [Related]
14. A microenvironment based model of antimitotic therapy of Gompertzian tumor growth.
Kozusko F; Bourdeau M; Bajzer Z; Dingli D
Bull Math Biol; 2007 Jul; 69(5):1691-708. PubMed ID: 17577604
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls.
de Pillis LG; Gu W; Fister KR; Head T; Maples K; Murugan A; Neal T; Yoshida K
Math Biosci; 2007 Sep; 209(1):292-315. PubMed ID: 17306310
[TBL] [Abstract][Full Text] [Related]
16. Optimal control of treatment in a mathematical model of chronic myelogenous leukemia.
Nanda S; Moore H; Lenhart S
Math Biosci; 2007 Nov; 210(1):143-56. PubMed ID: 17599363
[TBL] [Abstract][Full Text] [Related]
17. Robustness of optimal controls for a class of mathematical models for tumor anti-angiogenesis.
Schättler H; Ledzewicz U; Cardwell B
Math Biosci Eng; 2011 Apr; 8(2):355-69. PubMed ID: 21631134
[TBL] [Abstract][Full Text] [Related]
18. Optimal intervention strategies for cyclic therapeutic methods.
Vahedi G; Faryabi B; Chamberland JF; Datta A; Dougherty ER
IEEE Trans Biomed Eng; 2009 Feb; 56(2):281-91. PubMed ID: 19272947
[TBL] [Abstract][Full Text] [Related]
19. Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function.
Engelhart M; Lebiedz D; Sager S
Math Biosci; 2011 Jan; 229(1):123-34. PubMed ID: 21129386
[TBL] [Abstract][Full Text] [Related]
20. Cracking the mild, difficult and fiendish codes within and downstream of the EGFR to link diagnostics and therapeutics.
Waterfield M
Biochem Soc Trans; 2007 Feb; 35(Pt 1):1-6. PubMed ID: 17212578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
